It's time to evolve from Scadding: phenotyping sarcoidosis

Daniel A. Culver, Robert P. Baughman

Source: Eur Respir J, 51 (1) 1800050; 10.1183/13993003.00050-2018
Journal Issue: January

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Daniel A. Culver, Robert P. Baughman. It's time to evolve from Scadding: phenotyping sarcoidosis. Eur Respir J, 51 (1) 1800050; 10.1183/13993003.00050-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The radiological diagnosis of bronchiectasis: what's in a name?
Source: Eur Respir Rev, 29 (156) 190120; 10.1183/16000617.0120-2019
Year: 2020



It's not all asthma
Source: International Congress 2017 – GR6 Paediatric Ground Round: an interactive session
Year: 2017


What's new in sarcoidosis management?
Source: Annual Congress 2013 –ME5 What's new in sarcoidosis management?
Year: 2013



Unclassifiable interstitial lung disease: a pathologist's perspective
Source: Eur Respir Rev, 27 (147) 170132; 10.1183/16000617.0132-2017
Year: 2018



It's all in our genes
Source: International Congress 2019 – High-tech in interstitial lung diseases: just hype and gadgets?
Year: 2019


Different biopsy techniques for confirmation of sarcoidosis: The game for the best diagnostic yield is still open
Source: International Congress 2015 – Sarcoidosis: pathogenesis
Year: 2015


Koch's disease turns into tuberculosis
Source: Annual Congress 2008 - Lunchtime programme: Berlin - views and insights guided by the history of medicine
Year: 2008


Morphological features in different course of sarcoidosis, forecast opportunity.
Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Year: 2020


HLA-DRB1* alleles and symptoms associated with Heerfordt's syndrome in sarcoidosis
Source: Eur Respir J 2011; 38: 1151-1157
Year: 2011



Extrapulmonary sarcoidosis: what to look for and how to treat
Source: International Congress 2019 – State of the art session: Interstitial lung diseases
Year: 2019


Relapses of sarcoidosis: what are they and can we predict who will get them?
Source: Eur Respir J 2014; 43: 337-339
Year: 2013


On the application of corticotherapy into sarcoidosis: a decision rule based approach
Source: Eur Respir J 2005; 26: Suppl. 49, 330s
Year: 2005

Data of centre's studies on diagnosis of pleura lesions based on doctor's action algorithm
Source: Eur Respir J 2001; 18: Suppl. 33, 386s
Year: 2001

What's in a name? That which we call IPF, by any other name would act the same
Source: Eur Respir J, 51 (5) 1800692; 10.1183/13993003.00692-2018
Year: 2018



Escaping the Plato's cave of latent tuberculosis testing: a path for developers of predictive tests for risk of tuberculosis
Source: Eur Respir J, 52 (4) 1801616; 10.1183/13993003.01616-2018
Year: 2018



How to achieve the higher diagnostic yield using EBUS-TBNA method to confirm sarcoidosis?
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016


Lung cancer: keep your mind open – it's not always the usualsuspects!
Source: Breathe, 16 (1) 190363; 10.1183/20734735.0363-2019
Year: 2020



Novel drugs against tuberculosis: a clinician's perspective
Source: Eur Respir J 2015; 45: 1119-1131
Year: 2015



Diagnostic approach to environmental/occupational pulmonary disease; how to differentiate from 'idiopathic' lung disease
Source: Annual Congress 2004 - PG10 - Occupational and environmental disorders of the lung parenchyma
Year: 2004


Tuberculosis: considerations on the period between disease beginning and diagnosis moment
Source: Eur Respir J 2001; 18: Suppl. 33, 467s
Year: 2001